Author

S. Malvankar

OpenAlex ID: A5037200720

Creatinine Clearance Is Associated with Toxicity from Molecularly Targeted Agents in Phase I Trials

2012 · B. Basu, J. Vitfell-Pedersen, et al. · Oncology · 1

Front & Back Matter

2012 · S.B. Kaye, L.R. Molife, et al. · Oncology

1232 POSTER Creatinine Clearance (CrCI) as a Predictive Marker for the Risk of Toxicity From Molecularly Targeted Agents (MTA) in Phase I Trials

2011 · J. Vitfell-Pedersen, B. Basu, et al. · European Journal of Cancer

Works count: 3

Citation count: 1

H-index: 1

I10-index: